Melatonina Generis

Melatonin, the active ingredient in Melatonina Generis, is a melatonin receptor agonist presented as an oral formulation for oral use. It works by activating MT1 and MT2 receptors to promote sleep onset and is indicated for insomnia, jet lag and other sleep‑wake rhythm disorders in adults.

GNH USA supplies Melatonina Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU market standards and is manufactured under GMP conditions.

Melatonina Generis is a melatonin receptor agonist used to address disorders of the sleep‑wake cycle. - Insomnia: helps reduce sleep onset latency and improve sleep maintenance. - Jet lag: assists in resetting circadian rhythm after rapid time‑zone travel. - Sleep‑wake rhythm disorders: supports normalization of abnormal sleep patterns such as shift‑work disorder.

Melatonina Generis may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate pain often occurring shortly after ingestion. - Dizziness: sensation of light‑headedness or unsteadiness. - Daytime sleepiness: residual drowsiness during waking hours. - Nausea: mild gastrointestinal upset. - Vivid dreams: unusually intense or memorable dreaming. - Mild abdominal discomfort: occasional stomach cramps.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or hives. - Anaphylaxis: rare, severe hypersensitivity requiring immediate medical attention. - Mood changes: emergence of depression, anxiety or suicidal thoughts. - Cardiac arrhythmia: rare irregular heart rhythm. - Severe hypotension: unexpected drop in blood pressure.

When considering Melatonina Generis, several safety considerations should be observed. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Concomitant CNS depressants: monitor for additive sedation. - Autoimmune disease: use with caution as melatonin may modulate immune response. - Elderly patients: start with the lowest effective dose. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Melatonin can interact with several medication classes; awareness of these interactions helps optimize safety.

Major Interactions (Avoid): - Anticoagulants: may increase bleeding risk. - Immunosuppressants: may reduce therapeutic efficacy. - CYP1A2 inhibitors (e.g., fluvoxamine): can raise melatonin plasma levels.

Moderate Interactions (Monitor Closely): - CNS depressants (benzodiazepines, alcohol): additive sedation. - Antidiabetic drugs: potential alteration of glucose control. - Hormonal contraceptives: possible reduction in melatonin effectiveness.